This study is the multi-center, open and cross-sectional study of RA remission in Asia Pacific region. The objectives is to explore remission rate of RA patients in different countries in the Asian-Pacific area using different criteria of remission (DAS28, CDAI, SDAI, ACR/EULA remission criteria, RAPID3 and Clin28) and investigate the associated factors of remission in RA patients.
Study Type
OBSERVATIONAL
Enrollment
1,500
as clinical practice
remission rate of RA patients in different countries in the Asian-Pacific area
according to the different criteria of clinical remission in RA patients
Time frame: 12-24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.